Switch theme
Sign up to access all valuation multiples
APR Co Ltd is a company engaged in the business of beauty and skin care devices, fashion, and entertainment. First, as a beauty brand, there is a highly reliable derma skin care brand 'MediCube' that is widely loved not only in Korea but also in the global market.
2014
n/a
LTM Revenue $536M
LTM EBITDA $107M
$1.7B
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
APR Co. has a last 12-month revenue of $536M and a last 12-month EBITDA of $107M.
In the most recent fiscal year, APR Co. achieved revenue of $492M and an EBITDA of $109M.
APR Co. expects next 12-month revenue of XXX and NTM EBITDA of XXX
See APR Co. valuation multiples based on analyst estimates| FY 2023 | FY 2024 | FY 2025 | LTM | NTM | |
|---|---|---|---|---|---|
| Revenue | $357M | $492M | XXX | XXX | XXX |
| Gross Profit | $199M | $269M | XXX | XXX | XXX |
| Gross Margin | 56% | 55% | XXX | XXX | XXX |
| EBITDA | $82.5M | $109M | XXX | XXX | XXX |
| EBITDA Margin | 23% | 22% | XXX | XXX | XXX |
| Net Profit | $20.4M | $55.6M | XXX | XXX | XXX |
| Net Margin | 6% | 11% | XXX | XXX | XXX |
| Net Debt | n/a | n/a | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of April 15, 2025, APR Co.'s stock price is KRW 67600 (or $46).
APR Co. has current market cap of KRW 2.52T (or $1.7B), and EV of KRW 2.51T (or $1.7B).
See APR Co. trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $1.7B | $1.7B | XXX | XXX | XXX | XXX | $2.07 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Sign UpAs of April 15, 2025, APR Co. has market cap of $1.7B and EV of $1.7B.
APR Co.'s trades at 3.2x LTM EV/Revenue multiple, and 16.1x LTM EBITDA.
Analysts estimate APR Co.'s 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See valuation multiples for APR Co. and 10K+ public comps| FY 2024 | FY 2025E | FY 2026E | FY 2027E | |
|---|---|---|---|---|
| EV | $1.7B | XXX | XXX | XXX |
| EV/Revenue | 3.5x | XXX | XXX | XXX |
| EV/EBITDA | 15.8x | XXX | XXX | XXX |
| P/E | 23.5x | XXX | XXX | XXX |
| P/E/Growth | 0.9x | XXX | XXX | XXX |
| EV/FCF | 80.3x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Sign UpAPR Co.'s NTM/LTM revenue growth is 29%
APR Co.'s revenue per employee for the last fiscal year averaged n/a, while opex per employee averaged n/a for the same period.
Over next 12 months, APR Co.'s ratio of sales and marketing spend to revenue is estimated to be XXX , while its R&D spend to revenue to be XXX .
Analysts estimate APR Co.'s 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See operational valuation multiples for APR Co. and other 10K+ public comps| FY 2024 | NTM | FY 2025E | FY 2026E | FY 2027E | |
|---|---|---|---|---|---|
| Revenue Growth | 38% | XXX | XXX | XXX | XXX |
| EBITDA Margin | 22% | XXX | XXX | XXX | XXX |
| EBITDA Growth | 32% | XXX | XXX | XXX | XXX |
| Rule of 40 (SaaS-only) | 51% | XXX | XXX | XXX | XXX |
| Revenue per Employee | n/a | XXX | XXX | XXX | XXX |
| Opex per Employee | n/a | XXX | XXX | XXX | XXX |
| S&M Expenses to Revenue | 45% | XXX | XXX | XXX | XXX |
| G&A Expenses to Revenue | 3% | XXX | XXX | XXX | XXX |
| R&D Expenses to Revenue | 0% | XXX | XXX | XXX | XXX |
| Opex to Revenue | 58% | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Acme United | XXX | XXX | XXX | XXX | XXX | XXX |
| EZZ Life Science | XXX | XXX | XXX | XXX | XXX | XXX |
| Live Verdure | XXX | XXX | XXX | XXX | XXX | XXX |
| Lavipharm | XXX | XXX | XXX | XXX | XXX | XXX |
| Sarantis Group | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
APR Co. acquired XXX companies to date.
Last acquisition by APR Co. was XXXXXXXX, XXXXX XXXXX XXXXXX . APR Co. acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Sign Up| When was APR Co. founded? | APR Co. was founded in 2014. |
| Where is APR Co. headquartered? | APR Co. is headquartered in South Korea. |
| Who is the CEO of APR Co.? | APR Co.'s CEO is Mr. Byung-Hoon Kim. |
| Is APR Co. publicy listed? | Yes, APR Co. is a public company listed on KRX. |
| What is the stock symbol of APR Co.? | APR Co. trades under 278470 ticker. |
| When did APR Co. go public? | APR Co. went public in 2024. |
| Who are competitors of APR Co.? | Similar companies to APR Co. include e.g. Acme United, EZZ Life Science, Live Verdure, Lavipharm. |
| What is the current market cap of APR Co.? | APR Co.'s current market cap is $1.7B |
| What is the current revenue of APR Co.? | APR Co.'s last 12-month revenue is $536M. |
| What is the current EBITDA of APR Co.? | APR Co.'s last 12-month EBITDA is $107M. |
| What is the current EV/Revenue multiple of APR Co.? | Current revenue multiple of APR Co. is 3.2x. |
| What is the current EV/EBITDA multiple of APR Co.? | Current EBITDA multiple of APR Co. is 16.1x. |
| What is the current revenue growth of APR Co.? | APR Co. revenue growth between 2023 and 2024 was 38%. |
| Is APR Co. profitable? | Yes, APR Co. is EBITDA-positive (as of the last 12 months). |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
